Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples